Papers on JAK2 mutation

8 papers

Wednesday, September 16

Nature GeneticsSep 16

Type 1 interferon perturbates clonal competition by reshaping human blood development

Cohort study in peopleInterventions

Tuesday, September 8

British Journal of HaematologySep 8

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera

Cohort study of 664 peopleEstimated pulse wave velocity

Wednesday, August 26

Frontiers in OncologyAug 26

Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms

Impact of HU on NLR dynamics and prognostic relevance for thrombosis and mortality.

ReviewNeutrophil-to-lymphocyte ratio

Monday, May 18

Journal of Medical CasesMay 18

Isolated Neutropenia as a Sentinel of High-Risk Clonal Evolution: Acute Myeloid Leukemia With Myelodysplasia-Related Changes Harboring TP53 Deletion via Isochromosome 17q and Deletion 20q Mimicking a Myeloproliferative Neoplasm

Case reportBiomarkers

Wednesday, May 13

CancersMay 13

Clonal Hematopoiesis of Indeterminate Potential (CHIP): A Model of Mutation-Driven Thromboinflammation

ReviewBlood and immune system

Monday, August 5

BloodAug 5

JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism

Cohort study of 400,000 peopleThrombosis

Tuesday, August 9

HematologyAug 9

JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?

Case reportJAK2

Sunday, August 11

CellsAug 11

Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation

ReviewInflammation